Atlas Trials

Primary Mediastinal B Cell Lymphoma

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Mediastinal B Cell Lymphoma

RecordFirmDate
Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context (NCT06781450)IRCCS Azienda Ospedaliero-Universitaria di Bologna2022-04-23
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells (NCT04911478)Adicet Therapeutics2022-02-14
Immune Responses to COVID-19 Vaccination in Lymphoma Patients (NCT04858568)University Hospital Southampton NHS Foundation Trust2021-03-11
A Phase 1 Study of ADI-001 in B Cell Malignancies (NCT04735471)Adicet Therapeutics2021-03-04
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) (NCT02669017)ADC Therapeutics S.A.2016-03-01
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001) (NCT02631044)Juno Therapeutics, a Subsidiary of Celgene2016-01-06
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL (NCT02393157)New York Medical College2015-08-21
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) (NCT01953692)Merck Sharp & Dohme LLC2013-11-22
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma (NCT00924326)National Cancer Institute (NCI)2009-02-17
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma (NCT00944567)International Extranodal Lymphoma Study Group (IELSG)2007-01-01

Track Primary Mediastinal B Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.